Pod těmito názvy můžete látku najít v jiných zdrojích
GB226
FME52R2SGN
GENOLIMZUMAB
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)], MONOCLONAL ANTIBODY; PROPOSED INN LIST 123, REC. LIST 85
HUMANIZED IGG4 ANTIBODY DIRECTED AGAINST THE NEGATIVE IMMUNOREGULATORY HUMAN CELL SURFACE RECEPTOR PROGRAMMED CELL DEATH 1 (PD-1/PDCD1/PD1) WITH LOW ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AND COMPLEMENT-DEPENDENT CYTOTOXICITY